Synthesis of a Heterobifunctional PEG Spacer Terminated with Aminooxy and Bromide Functionality

Christopher W. Dicus; Michael H. Nantz

doi:10.1055/s-2006-950246

Subscribe to RSS

Please copy the URL and add it into your RSS Feed Reader.

https://www.thieme-connect.de/rss/thieme/en/10.1055-s-00000083.xml

Share / Bookmark

Facebook X Linkedin Weibo

Download PDF

Synlett 2006(17): 2821-2823
DOI: 10.1055/s-2006-950246

LETTER

Synthesis of a Heterobifunctional PEG Spacer Terminated with Aminooxy and Bromide Functionality

Christopher W. Dicus, Michael H. Nantz
Department of Chemistry, University of California Davis, Davis, CA 95616, USA
Fax: +1(502)8527214; e-Mail: michael.nantz@louisville.edu;

Further Information

Publication History

Received 12 June 2006
Publication Date:
09 October 2006 (online)

Abstract
Full Text
References

Permissions and Reprints All articles of this category

Abstract

A simple and efficient synthesis of a novel heterobifunctional polyethylene glycol (PEG) spacer is described. The PEG spacer reagent is terminated with aminooxy and bromide functionality for ease of conjugation to a variety of electrophiles and/or nucleophiles.

Key words

heterobifunctional PEG - aminooxy - bioconjugation - molecular recognition - OEG - spacer

References and Notes

2a Bailon P. Berthold W. Pharm. Sci. Technol. Today 1998, 352

Google Scholar
2b Veronese FM. Biomaterials 2001, 405

Google Scholar
2c Pasut G. Veronese FM. Adv. Polym. Sci. 2006, 95

Google Scholar
3 Dreborg S. Akerblom EB. Crit. Rev. Ther. Drug Carrier Syst. 1990, 315

Google Scholar
4 Smaller PEG units (MW <500), also referred to as oligoethylene glycol (OEG), often are employed as spacers; see, for example: Engel A. Chatterjee SK. Al-Arifi A. Riemann D. Langner J. Nuhn P. Pharm. Res. 2003, 51

Crossref Google Scholar
For recent examples, see:
5a Chen H. Chen Y. Sheardown H. Brook MA. Biomaterials 2005, 7418

Crossref Google Scholar
5b Otsuka H. Nagasaki Y. Kataoka A. Langmuir 2004, 11285

Crossref Google Scholar
5c Manta C. Ferraz N. Betancor L. Antunes G. Batista-Viera F. Carlsson J. Caldwell K. Enzyme Microb. Technol. 2003, 890

Crossref Google Scholar
For recent reviews, see:
6a Kichler A. J. Gene Med. 2004, S3

Crossref Google Scholar
6b Kircheis R. Wightman L. Wagner E. Adv. Drug Delivery Rev. 2001, 341

Crossref Google Scholar
7 Kleemann E. Neu M. Jekel N. Fink L. Schmehl T. Gessler T. Seeger W. Kissel T. J. Controlled Release 2005, 299

Crossref Google Scholar
8 Kim WJ. Yockman JW. Lee M. Jeong LH. Kim Y.-H. Kim SW. J. Controlled Release 2005, 224

Crossref Google Scholar
9 Roberts MJ. Bentley MD. Harris JM. Adv. Drug Delivery Rev. 2002, 459

Crossref Google Scholar
10 Engel A. Chatterjee SK. Al-Arifi A. Nuhn P. J. Pharm. Sci. 2003, 2229

Crossref Google Scholar
11 Loiseau FA. Hii KK. Hill AM. J. Org. Chem. 2004, 639

Crossref Google Scholar
12 Goodson RJ. Katre NV. Biotechnology (N.Y.) 1990, 8: 343

Crossref Google Scholar
13 Morpurgo M. Veronese FM. Kachensky D. Harris JM. Bioconjugate Chem. 1996, 7: 363

Crossref Google Scholar
14 Woghiren C. Sharma B. Stein S. Bioconjugate Chem. 1993, 4: 314

Crossref Google Scholar
15 Tumelty D. Carnevali M. Miranda LP. J. Am. Chem. Soc. 2003, 14238

Crossref Google Scholar
16a Lemieux GA. Yarema KJ. Jacobs CL. Bertozzi CR. J. Am. Chem. Soc. 1999, 4278

Crossref Google Scholar
16b Sadamoto R. Niikura K. Ueda T. Monde K. Fukuhara N. Nishimura S.-I. J. Am. Chem. Soc. 2004, 3755

Crossref Google Scholar
17 Perouzel E. Jorgensen MR. Keller M. Miller AD. Bioconjugate Chem. 2003, 14: 884

Crossref Google Scholar
18 Bertozzi CR. Bednarski MD. J. Org. Chem. 1991, 4326

Crossref Google Scholar
20a Grochowski E. Jurczak J. Synthesis 1976, 682

Crossref Google Scholar
20b Nicolaou KC. Groneberg RD. J. Am. Chem. Soc. 1990, 4085

Crossref Google Scholar
20c Su S. Giguere JR. Schaus SE. Porco JA. Tetrahedron 2004, 8645

Crossref Google Scholar
21 Appel R. Angew. Chem., Int. Ed. Engl. 1975, 14: 801

Crossref Google Scholar
23 Gaertner HF. Offord RE. Bioconjugate Chem. 1996, 7: 38

Crossref Google Scholar

1

Present address: Department of Chemistry, University of Louisville, Louisville, KY 40292, USA

19

For moisture-sensitive reactions, optimized yields were obtained only after drying the PEG intermediate by toluene azeotropic distillation immediately prior to use.

22

¹H NMR and ¹³C NMR data (300 MHz and 75 MHz, respectively; in CDCl₃) for all compounds: Compound 1a: ¹H NMR: δ = 7.23 (br s, 1 H), 4.03 (m, 2 H), 3.82 (t, J = 6.3 Hz, 2 H), 3.74 (m, 2 H), 3.69 (app. s, 4 H), 3.48 (t, J = 6.3 Hz, 2 H), 1.48 (s, 9 H). ¹³C NMR: δ = 156.7, 81.7, 75.4, 71.2, 70.5, 70.4, 69.4, 30.2, 28.2.
Compound 1b: ¹H NMR: δ = 7.59 (br s, 1 H), 4.03 (m, 2 H), 3.82 (t, J = 6.3 Hz, 2 H), 3.70-3.66 (m, 8 H), 3.48 (t, J = 6.3 Hz, 2 H), 1.48 (s, 9 H). ¹³C NMR: δ = 156.7, 81.5, 75.3, 71.2, 70.6 (3 C), 70.5, 69.3, 30.2, 28.2.
Compound 3a: ¹H NMR: δ = 7.70-7.67 (m, 4 H), 7.44-7.35 (m, 6 H), 3.82 (t, J = 5.4 Hz, 2 H), 3.73-3.70 (m, 2 H), 3.66 (app. s, 4 H), 3.63 (m, 4 H), 2.17 (br s, 1 H), 1.05 (s. 9 H). ¹³C NMR: δ = 135.6, 133.6, 129.6, 127.6, 72.5, 70.8, 70.5, 63.4, 61.8, 26.8, 19.2.
Compound 3b: ¹H NMR: δ = 7.70-7.67 (m, 4 H), 7.44-7.35 (m, 6 H), 3.82 (t, J = 5.4 Hz, 2 H), 3.73-3.70 (m, 2 H), 3.66-3.58 (m, 12 H), 2.25 (br s, 1 H), 1.05 (s, 9 H). ¹³C NMR: δ = 135.6, 133.6, 129.6, 127.6, 72.5, 72.4, 70.7, 70.7, 70.4, 63.4, 61.8, 26.8, 19.2.
Compound 4a: ¹H NMR: δ = 7.83-7.80 (m, 2 H), 7.72-7.70 (m, 2 H), 7.70-7.65 (m, 4 H), 7.44-7.35 (m, 6 H), 4.36 (m, 2 H), 3.86 (m, 2 H), 3.74 (t, J = 5.4 Hz, 2 H), 3.65-3.62 (m, 2 H), 3.58-3.56 (m, 2 H), 3.52 (t, J = 5.4 Hz, 2 H), 1.03 (s, 9 H). ¹³C NMR: δ = 163.4, 135.6, 134.4, 133.7, 129.6, 129.0, 127.6, 123.4, 77.2, 72.4, 70.8, 70.7, 69.4, 63.3, 26.8, 19.2.
Compound 4b: ¹H NMR: δ = 7.84-7.81 (m, 2 H), 7.74-7.71 (m, 2 H), 7.70-7.66 (m, 4 H), 7.44-7.34 (m, 6 H), 4.36 (m, 2 H), 3.85 (m, 2 H), 3.79 (t, J = 5.4 Hz, 2 H), 3.67-3.63 (m, 2 H), 3.61-3.52 (m, 8 H), 1.04 (s, 9 H). ¹³C NMR: δ = 163.4, 135.6, 134.4, 133.7, 129.6, 129.0, 127.6, 77.2, 72.4, 70.8, 70.7, 70.6, 70.5, 69.3, 63.4, 26.8, 19.2.
Compound 5a: ¹H NMR: δ = 7.70-7.67 (m, 4 H), 7.44-7.35 (m, 6 H), 3.84 (m, 2 H), 3.81 (t, J = 5.4 Hz, 2 H), 3.69-3.59 (m, 8 H), 1.05 (s, 9 H). ¹³C NMR: δ = 135.6, 133.6, 129.6, 127.6, 74.7, 72.4, 70.7, 70.6, 69.7, 63.4, 26.8, 19.2.
Compound 5b: ¹H NMR: δ = 7.70-7.67 (m, 4 H), 7.44-7.35 (m, 6 H), 3.85 (m, 2 H), 3.81 (t, J = 5.4 Hz, 2 H), 3.69-3.63 (m, 10 H), 3.60 (t, J = 5.4 Hz, 2 H), 1.05 (s, 9 H). ¹³C NMR: δ = 135.6, 133.6, 129.6, 127.6, 74.6, 72.4, 70.7, 70.6, 70.5, 70.5, 69.7, 63.4, 26.8, 19.2.
Compound 6a: ¹H NMR: δ = 7.70-7.67 (m, 4 H), 7.51 (br s, 1 H), 7.44-7.34 (m, 6 H), 4.01 (m, 2 H), 3.82 (t, J = 5.4 Hz, 2 H), 3.72 (m, 2 H), 3.68-3.62 (m, 4 H), 3.61 (t, J = 5.4 Hz, 2 Hz), 1.46 (s, 9 H), 1.05 (s, 9 H). ¹³C NMR: δ = 156.7, 135.6, 133.6, 129.6, 127.6, 81.5, 75.3, 72.4, 70.7, 70.6, 69.4, 63.4, 28.2, 26.8, 19.2.
Compound 6b: ¹H NMR: δ = 7.70-7.67 (m, 4 H), 7.62 (br s, 1 H), 7.44-7.34 (m, 6 H), 4.01 (m, 2 H), 3.81 (t, J = 5.4 Hz, 2 H), 3.70 (m, 2 H), 3.67-3.62 (m, 8 H), 3.60 (t, J = 5.4 Hz, 2 H), 1.46 (s, 9 H), 1.05 (s, 9 H). ¹³C NMR: δ = 156.7, 135.6, 133.6, 129.6, 127.6, 81.4, 75.3, 72.3, 70.7, 70.6, 70.5, 70.5, 69.2, 63.4, 28.2, 26.8, 19.1.
Compound 7a: ¹H NMR: δ = 7.82 (br s, 1 H), 4.03 (m, 2 H), 3.76-3.72 (m, 4 H), 3.69 (s, 4 H), 3.64-3.61 (m, 4 H), 2.84 (br s, 1 H), 1.48 (s, 9 H). ¹³C NMR: δ = 156.8, 81.6, 75.2, 72.6, 70.4, 70.2, 69.2, 61.6, 28.2.
Compound 7b: ¹H NMR: δ = 8.08 (br s, 1 H), 4.02 (m, 2 H), 3.74-3.66 (m, 12 H), 3.63 (m, 2 H), 2.80 (br s, 1 H), 1.48 (s, 9 H). ¹³C NMR: δ = 156.9, 81.4, 75.1, 72.6, 70.6, 70.4, 70.4, 70.3, 69.0, 61.7, 28.2.

24

Compound 9 was obtained as a single isomer: ¹H NMR (600 MHz, CDCl₃): δ = 8.13 (s, 1 H), 7.58-7.57 (m, 2 H), 7.38-7.36 (m, 3 H), 4.34 (t, J = 4.6 Hz, 2 H), 3.83-3.81 (m, 4 H), 3.70 (app. s, 4 H), 3.46 (t, J = 6.0 Hz, 2 H). ¹³C NMR (75 MHz, CDCl₃): δ = 149.0, 132.2, 129.8, 128.7, 127.0, 73.5, 71.2, 70.7, 70.5, 69.7, 30.3.